CERO THERAPEUTICS HOLDINGS, INC. — Form D
CERO THERAPEUTICS HOLDINGS, INC. of SOUTH SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-02-23. The offering totals $10.2M, of which $10.2M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2024-02-23
- Form: D
- Accession: 0001802806-24-000016
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $10.2M
- Amount sold: $10.2M
- Investors: 46
- Date of first sale: 2024-02-14
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-506000
Issuer
- Name: CERO THERAPEUTICS HOLDINGS, INC.
- CIK: 0001870404
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 201 HASKINS WAY, SOUTH SAN FRANCISCO, CA, 94080
- Phone: 650-407-2376
Officers, directors & promoters (19)
| Name | Role | Location |
|---|
| Michael Byrnes | Director | Philadelphia, PA |
| Robyn Rapaport | Director | South San Francisco, CA |
| Lindsey Rolfe | Director | South San Francisco, CA |
| Brian Atwood | Executive Officer | South San Francisco, CA |
| Shami G Patel | Director | South San Francisco, CA |
| Kristen Albert Pierce | Executive Officer | South San Francisco, CA |
| Lindsey G Rolfe | Director | South San Francisco, CA |
| Kathleen G LaPorte | Director | South San Francisco, CA |
| Andrew Albert Kucharchuk | Executive Officer | South San Francisco, CA |
| Chris Ehrlich | Director | South San Francisco, CA |
| Chris Ehrlich | Executive Officer | South San Francisco, CA |
| Michael G Byrnes | Director | South San Francisco, CA |
| Michael Albert Byrnes | Director | South San Francisco, CA |
| Brian Atwood | Director | South San Francisco, CA |
| Lindsey Albert Rolfe | Director | South San Francisco, CA |
| Chris Albert Ehrlich | Director | South San Francisco, CA |
| Chris Albert Ehrlich | Executive Officer | South San Francisco, CA |
| Kathleen Albert LaPorte | Director | South San Francisco, CA |
| Brian G Atwood | Director | Gaithersburg, MD |
Other filings by this issuer (2)
More